Initial Single-Center Experience With Levosimendan Infusion for Perioperative Management of Univentricular Heart With Ductal-Dependent Systemic Circulation

World Journal for Pediatric and Congenital Heart Surgery

Volumn 1, Issue 3, 2010, Pages 292-299

  Garisto, Cristiana ^a   Favia, Isabella ^a   Ricci, Zaccaria ^a   Chiara, Luca di ^a   Morelli, Stefano ^a   Giorni, Chiara ^a   Vitale, Vincenzo ^a   Picardo, Sergio ^a   di Donato, Roberto M ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

inotropic score; levosimendan; pediatric cardiac surgery; univentricular heart

Indexed keywords

EID: 84990347713     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135110378310     Document Type: Article

References (37)

1. Cavusoglu Y. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Expert Opin Pharmacother. 2007; 8: 665–677.
2. De Hert SG Lorsomradee S Van Den Eede H, et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth. 2008; 22: 699–705.
3. Tritapepe L De Santis V Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting: a pilot study. Br J Anaesth. 2006; 96: 694–700.
4. Shore S Nelson D Pearl J, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol. 2001; 88: 591–594.
5. Andropoulos DB Ogletree ML. Physiology and molecular biology of the developing circulation. In: Andropoulos DB, Stayer SA, Russell IA, eds. Anesthesia for Congenital Heart Disease. Malden, MA: Blackwell Futura; 2005: 30–45.
6. Artman M Mahoney L Teidel DF. Regulation of myocyte contraction and relaxation. In: Artman M, Mahoney L, Teidel DF, eds. Neonatal Cardiology. New York: McGraw-Hill; 2002: 19–37.
7. Than N Shah N White J, et al. Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents. Cardiovasc Res. 1994; 28: 1209–1217.
8. O’Connor WN Cash JB Cottrill CM, et al. Ventriculocoronary connections and hypoplastic left hearts: an autopsy microscopic study. Circulation. 1982; 66: 1078–1086.
9. Sugiyama H Yutani C Iida K, et al. The relation between right ventricular function and left ventricular morphology in hypoplastic left heart syndrome: angiographic and pathologic studies. Pediatr Cardiol. 1999; 20: 422–427.
10. Alcaraz AJ Sancho L Manzano L, et al. Newborn patients exhibit an unusual pattern of interleukin 10 and interferon gamma serum levels in response to cardiac surgery. J Thorac Cardiovasc Surg. 2002; 123: 451–458.
11. Hovels-Gurich HH Vazquez-Jimenez JF Silvestri A, et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 2002; 124: 811–820.
12. Qing M Schumacher K Heise R, et al. Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Card. 2003; 41: 2263–2274.
13. Hammon JW. Myocardial protection in the immature heart. Ann Thorac Surg. 1995; 60: 839–842.
14. Pujiwara T Kurtts T Anderson W, et al. Myocardial protection in cyanotic neonatal limbs. J Thorac Cardiovasc Surg. 1988; 96: 700–710.
15. Silverman NA Kohler J Levitsky S, et al. Chronic hypoxemia depresses global ventricular function and predisposes to depletion of high energy phosphates during cardioplegic arrest: implications for surgical repair of cyanotic congenital heart defects. Ann Thorac Surg. 1984; 37: 304–308.
16. Hammon JW Jr Graham TP Jr Boucek RJ Jr, et al. Myocardial adenosine triphosphate content as a measure of metabolic and functional myocardial protection in children undergoing cardiac operation. Ann Thorac Surg. 1987; 44: 467–470.
17. Lupinetti FM Wareing TH Huddleston CB, et al. Pathophysiology of chronic cyanosis in a canine model: functional and metabolic response to global ischemia. J Thorac Cardiovasc Surg. 1985; 90: 291–296.
18. Li J Hoschtitzky A Allen ML, et al. An analysis of oxygen consumption and oxygen delivery in euthermic infants after cardiopulmonary bypass with modified ultrafiltration. Ann Thorac Surg. 2004; 78: 1389–1396.
19. Cori CF Buchwald KW. Effect of continuous injection epinephrine on the carbohydrate metabolism, basal metabolism and vascular system of normal man. Am J Physiol. 2006; 95: 71–78.
20. Atgie C D’Allaire F Bukowiecki LJ. Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. Am J Physiol. 1997; 273: C1136–C1142.
21. Zhao J Cannon B Nedergaard J. Alpha1-adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells. J Biol Chem. 1997; 272: 32847–32856.
22. Skala JP Shaikh IM. Alpha 2-adrenergic receptors in brown adipose tissue of infant rats—II. Studies on function and regulation. Int J Biochem. 1988; 20: 15–22.
23. Nisoli E Tonello C Memo M, et al. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue: its role in modulating sympathetic stimulation induced thermogenesis. J Pharmacol Exp Ther. 1992; 263: 823–829.
24. Li J Zhang G Holtby H, et al. Adverse effects of dopamine on systemic hemodynamic status and oxygen transport in neonates after the Norwood procedure. J Am Coll Cardiol. 2006; 48: 1859–1864.
25. Stocker CF Shekerdemian LS N⊘rgaard MA, et al. Mechanism of reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Pediatr Crit Care. 2007; 35: 252–259.
26. Haikala H Linden IB. Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol. 1995; 26(Supplement 1):S10–S19.
27. Sonntag S Sundberg S Lehtonen LA, et al. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol. 2004; 43: 2177–2182.
28. Lilleberg J Ylonen V Lehtonen L, et al. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J. 2004; 38: 80–84.
29. Kopustinskiene D Pollesello P Saris N. Levosimendan is a mitochondrial KATP channel opener. Eur J Pharmacol. 2001; 428: 311–314.
30. Pollesello P Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care. 2004; 10: 436–441.
31. Di Chiara L Ricci Z Garisto C, et al. Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome. Pediatr Cardiol. 2010; 31: 166–167.
32. Hoffman GM Ghanayem NS Kampine JM, et al. Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome. Ann Thorac Surg. 2000; 70: 1515–1520.
33. Tweddell JS Ghanayem NS Mussatto KA, et al. Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg. 2007; 84: 1301–1310.
34. Tweddell JS Hoffman GM Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002; 106: I82–I89.
35. Tortoriello TA Stayer SA Mott AR, et al. A noninvasive estimation of mixed venous oxygen saturation using near-infrared spectroscopy by cerebral oximetry in pediatric cardiac surgery patients. Paediatr Anaesth. 2005; 15: 495–503.
36. Charpie JR Dekeon MK Goldberg CS, et al. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg. 2000; 120: 73–80.
37. Jacobs JP Jacobs ML Mavroudis C Lacour-Gayet FG Tchervenkov CI. Executive Summary: The Society of Thoracic Surgeons Congenital Heart Surgery Database—Eleventh Harvest (July 1, 2005–June 30, 2009). Durham, NC: The Society of Thoracic Surgeons (STS) and Duke Clinical Research Institute (DCRI), Duke University Medical Center; 2009.